Trial Outcomes & Findings for Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images (NCT NCT02596854)

NCT ID: NCT02596854

Last Updated: 2018-06-18

Results Overview

Images were read by board-certified radiologists who reviewed each image and assessed it on a 5 Point scale (1=unacceptable, 2=poor image quality, 3=Acceptable, 4=Good, 5=Excellent) based on the quality of the image (eg, signal-to-noise, clarity of anatomic boundaries, and other parameters). The outcome was reported as the mean diagnostic image quality score difference (synthetic - conventional).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

117 participants

Primary outcome timeframe

1 day

Results posted on

2018-06-18

Participant Flow

A single arm of subjects was enrolled and analyzed. Scanner selection (1.5T or 3.0T) was based on availability at the site and assigned by the site. Only one arm assignment (neurological MRI population) was per-protocol.

Participant milestones

Participant milestones
Measure
Neurological MRI
Image acquired for post processing with synthetic software Neurological MRI: Neurological MRI image collection
Overall Study
STARTED
117
Overall Study
COMPLETED
109
Overall Study
NOT COMPLETED
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Neurological MRI
Image acquired for post processing with synthetic software Neurological MRI: Neurological MRI image collection
Overall Study
Withdrawn
8

Baseline Characteristics

Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Neurological MRI
n=117 Participants
Image acquired for post processing with synthetic software Neurological MRI: Neurological MRI image collection
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
107 Participants
n=5 Participants
Age, Categorical
>=65 years
10 Participants
n=5 Participants
Age, Continuous
53.1 years
n=5 Participants
Sex: Female, Male
Female
67 Participants
n=5 Participants
Sex: Female, Male
Male
50 Participants
n=5 Participants
Region of Enrollment
United States
117 Participants
n=5 Participants
Static Field Strength of MRI Scans
1.5T Scans
58 Participants
n=5 Participants
Static Field Strength of MRI Scans
3.0T Scans
59 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 day

Population: Clinical indication for MRI of the brain based on site standard of care. This is a crossover study design where all subjects are enrolled into a single group producing two data types. The hypothesis test is a function of conventional and post-processed image quality within this patient group (one value summarized for this single population).

Images were read by board-certified radiologists who reviewed each image and assessed it on a 5 Point scale (1=unacceptable, 2=poor image quality, 3=Acceptable, 4=Good, 5=Excellent) based on the quality of the image (eg, signal-to-noise, clarity of anatomic boundaries, and other parameters). The outcome was reported as the mean diagnostic image quality score difference (synthetic - conventional).

Outcome measures

Outcome measures
Measure
Neurological MRI
n=109 Participants
Image acquired for post processing with synthetic software Neurological MRI: Neurological MRI image collection
Mean Diagnostic Image Quality Difference Between Conventional Versus Synthetic MR Utilizing a 5 Point Likert Scale
-0.335 units on a 5-point scale
Standard Deviation 0.3522

Adverse Events

Neurological MRI

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Neurological MRI
n=117 participants at risk
Image acquired for post processing with synthetic software Neurological MRI: Neurological MRI image collection
General disorders
Moderate Claustrophobia
0.85%
1/117 • Number of events 1
General disorders
mild anxiety
0.85%
1/117 • Number of events 1

Additional Information

John Strohmeyer

GE Healthcare

Phone: 609-865-7423

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place